The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
暂无分享,去创建一个
Paul A Clemons | Aravind Subramanian | Steven A Carr | Guo Wei | Ru Wei | Todd R Golub | Eric S Lander | Michael Reich | Stephen J Haggarty | Jean-Philippe Brunet | Jim Lerner | Justin Lamb | Emily D Crawford | David Peck | Joshua W Modell | Irene C Blat | Matthew J Wrobel | Kenneth N Ross | Haley Hieronymus | Scott A Armstrong | E. Lander | T. Golub | J. Lamb | E. Crawford | David Peck | Joshua W. Modell | Irene C. Blat | Jim Lerner | Jean-Philippe Brunet | A. Subramanian | K. Ross | Michael Reich | H. Hieronymus | G. Wei | S. Armstrong | S. Haggarty | P. Clemons | Ru Wei | S. Carr | M. Reich | S. Armstrong
[1] A. Chadli. THE CANCER CELL , 1924, La Presse medicale.
[2] D. Wolfe,et al. Nonparametric Statistical Methods. , 1974 .
[3] W. McGuire,et al. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. , 1978, Endocrinology.
[4] J Y Vanderhoek,et al. Local anesthetics, chlorpromazine and propranolol inhibit stimulus-activation of phospholipase A2 in human platelets. , 1979, Molecular pharmacology.
[5] D. Edwards,et al. 17α-Estradiol Is a Biologically Active Estrogen in Human Breast Cancer Cells in Tissue Culture* , 1980 .
[6] C. Geary. Leukemia , 1984, British Journal of Cancer.
[7] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[8] S. Khalid,et al. Isolation and characterization of an antimalarial agent of the neem tree Azadirachta indica. , 1989, Journal of natural products.
[9] B. Mylari,et al. 1,2-Dihydro-1-oxopyrrolo[3,2,1-kl]phenothiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with antiinflammatory activity. , 1990, Journal of medicinal chemistry.
[10] R. Pieters,et al. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia , 1991, The Lancet.
[11] A. Wakeling,et al. A potent specific pure antiestrogen with clinical potential. , 1991, Cancer research.
[12] AC Tose. Cell , 1993, Cell.
[13] B. Spiegelman,et al. 15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ , 1995, Cell.
[14] J. Lehmann,et al. An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.
[15] T. Hongo,et al. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. , 1997, Blood.
[16] P. Brown,et al. Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.
[17] R. Pieters,et al. In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia , 1997 .
[18] J. Lehmann,et al. Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs* , 1997, The Journal of Biological Chemistry.
[19] H P Koeffler,et al. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. , 1998, Cancer research.
[20] R. Pieters,et al. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. , 1998, Blood.
[21] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[22] Yudong D. He,et al. Functional Discovery via a Compendium of Expression Profiles , 2000, Cell.
[23] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[24] R G Ulrich,et al. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. , 2001, Toxicology and applied pharmacology.
[25] K Kosaka,et al. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. , 2001, Biochemical and biophysical research communications.
[26] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[27] T. Poggio,et al. Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.
[28] Gabriela Chiosis,et al. BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90. , 2002, Blood.
[29] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[30] K. Glaser,et al. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. , 2003, Molecular cancer therapeutics.
[31] T. Golub,et al. A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.
[32] I. P. López,et al. DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. , 2003, Obesity research.
[33] T. Larsen,et al. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? , 2003, International Journal of Obesity.
[34] W. Tissing,et al. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia , 2003, Leukemia.
[35] G. Gores,et al. Calpains Can Do It Alone: Implications for Cancer Therapy , 2003, Cancer biology & therapy.
[36] John H Kersey,et al. FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] M. Tabaton,et al. Microarray Analysis in Alzheimer's Disease and Normal Aging , 2004, IUBMB life.
[38] Kate A. Stafford,et al. Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Frasor,et al. Selective Estrogen Receptor Modulators , 2004, Cancer Research.
[40] E. Hennessy,et al. Synthesis of 4,5-dianilinophthalimide and related analogues for potential treatment of Alzheimer's disease via palladium-catalyzed amination. , 2005, The Journal of organic chemistry.
[41] M. Fielden,et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. , 2005, Journal of biotechnology.
[42] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[43] Gert R. G. Lanckriet,et al. Classification of a large microarray data set: algorithm comparison and analysis of drug signatures. , 2005, Genome research.
[44] M. Fielden,et al. A Gene Expression Signature that Predicts the Future Onset of Drug-Induced Renal Tubular Toxicity , 2005, Toxicologic pathology.